gvtcx

Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Statuscomplete
Proceduredirect
SME suitableYes
OCIDocds-h6vhtk-060e0f

Awards (3)

This procurement was awarded to 3 suppliers. Values shown are per-award; the notice total is ·.

SupplierValueDateStatus
Bath ASU shared £9,000,000 31 Mar 2026 pending
Baxter Healthcare Ltd shared £9,000,000 31 Mar 2026 pending
ITH Pharma Ltd shared £9,000,000 31 Mar 2026 pending

description

The current contract is due to expire on 30 June 2026. To maintain continuity of patient care and ensure uninterrupted product and service delivery, EMPC will extend the existing agreements with current Awarded Suppliers for a further 12 months from 1st July 2026 until 30th June 2027.

This is following the Transparency Notice published on the Find a Tender portal on 26th January 2026.

Notice identifier: 2026/S 000-006485.

Full justification has been provided in the Transparency Notice.

Pre-market Engagement Notice published on 12th May 1015

Notice identifier: 2025/S 000-020394

EMPC are in the process of undertaking Spend Controls approval and new Procurement Timescales will be communicated as soon as possible.

This extension has been awarded to:

Bath ASU

Baxter Healthcare Limited

ITH Pharma Ltd

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
26 Jan 2026 Transparency notice (UK5) Procurement Act 2023 006485-2026
7 Apr 2026 Contract award (UK6) Procurement Act 2023 031428-2026

more from University Hospitals of Derby and Burton NHS Foundation Trust

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.